Expression/NN
of/IN
A-myb/NN
,/,
but/CC
not/RB
c-myb/NN
and/CC
B-myb/NN
,/,
is/VBZ
restricted/JJ
to/TO
Burkitt/NN
's/POS
lymphoma/NN
,/,
sIg+/NN
B-acute/JJ
lymphoblastic/JJ
leukemia/NN
,/,
and/CC
a/DT
subset/NN
of/IN
chronic/JJ
lymphocytic/JJ
leukemias/NNS
./.

The/DT
A-myb/NN
gene/NN
encodes/VBZ
a/DT
transcription/NN
factor/NN
that/WDT
is/VBZ
related/JJ
both/CC
functionally/RB
and/CC
structurally/RB
to/TO
the/DT
v-myb/NN
oncogene/NN
./.
=====
Following/VBG
our/PRP$
observations/NNS
that/IN
A-myb/NN
is/VBZ
expressed/VBN
in/IN
a/DT
restricted/JJ
subset/NN
of/IN
normal/JJ
mature/JJ
human/JJ
B/NN
lymphocytes/NNS
,/,
with/IN
the/DT
phenotype/NN
CD38+/NN
,/,
CD39-/NN
,/,
slgM-/JJ
,/,
we/PRP
have/VBP
now/RB
investigated/VBN
the/DT
pattern/NN
of/IN
A-myb/NN
expression/NN
in/IN
neoplastic/JJ
B/NN
cells/NNS
representating/VBG
the/DT
whole/JJ
spectrum/NN
of/IN
B-cell/NN
differentiation/NN
and/CC
compared/VBD
it/PRP
to/TO
that/DT
of/IN
c-myb/NN
and/CC
B-myb/NN
./.
=====
In/IN
a/DT
panel/NN
of/IN
32/CD
B-cell/NN
lines/NNS
,/,
A-myb/NN
was/VBD
very/RB
strongly/RB
expressed/VBN
in/IN
most/JJS
Burkitt/NN
's/POS
lymphoma/NN
(/(
BL/NN
)/)
cell/NN
lines/NNS
,/,
but/CC
weak/JJ
or/CC
negative/JJ
in/IN
2/CD
pre-B/NN
acute/JJ
lymphoblastic/JJ
leukemia/NN
(/(
ALL/NN
)/)
,/,
4/CD
non-Hodgkin/JJ
's/POS
lymphoma/NN
(/(
NHL/NN
)/)
,/,
6/CD
Epstein-Barr/JJ
virus-immortalized/JJ
lymphoblastoid/JJ
cell/NN
lines/NNS
,/,
and/CC
6/CD
myeloma/NN
lines/NNS
./.
=====
Protein/NN
expression/NN
paralleled/VBD
that/DT
of/IN
the/DT
RNA/NN
./.
=====
We/PRP
have/VBP
also/RB
investigated/VBN
A-myb/NN
expression/NN
in/IN
49/CD
fresh/JJ
cases/NNS
of/IN
B/NN
leukemias/NN
./.
=====
Among/IN
24/CD
ALL/NN
,/,
6/CD
were/VBD
of/IN
the/DT
null/JJ
and/CC
11/CD
of/IN
the/DT
common/JJ
type/NN
and/CC
all/DT
these/DT
were/VBD
negative/JJ
for/IN
A-myb/NN
expression/NN
;/:
on/IN
the/DT
other/JJ
hand/NN
,/,
all/DT
7/CD
B-ALL/NN
cases/NNS
(/(
slg+/JJ
)/)
,/,
as/RB
well/RB
as/IN
one/CD
fresh/JJ
BL/NN
case/NN
with/IN
bone/NN
marrow/NN
infiltration/NN
,/,
expressed/VBD
A-myb/NN
./.
=====
A-myb/NN
was/VBD
undetectable/JJ
in/IN
4/CD
prolymphocytic/JJ
leukemias/NNS
(/(
PLL/NN
)/)
but/CC
was/VBD
strongly/RB
expressed/VBN
in/IN
5/20/CD
(/(
25/CD
%/NN
)/)
of/IN
chronic/JJ
lymphocytic/JJ
leukemia/NN
(/(
CLL/NN
)/)
samples/NNS
./.
=====
In/IN
the/DT
latter/JJ
A-myb/NN
did/VBD
not/RB
correlate/VB
with/IN
phenotype/NN
or/CC
clinical/JJ
stage/NN
./.
=====
Finally/RB
,/,
we/PRP
have/VBP
studied/VBN
the/DT
progression/NN
of/IN
one/CD
case/NN
of/IN
CLL/NN
into/IN
Richter/NN
's/POS
syndrome/NN
and/CC
have/VBP
found/VBN
that/IN
the/DT
Richter/NN
's/POS
cells/NNS
expressed/VBD
about/RB
25-fold/RB
less/JJR
A-myb/NN
RNA/NN
than/IN
the/DT
CLL/NN
cells/NNS
from/IN
the/DT
same/JJ
patient/NN
./.
The/DT
pattern/NN
of/IN
c-myb/NN
and/CC
B-myb/NN
was/VBD
clearly/RB
distinct/JJ
from/IN
that/DT
of/IN
A-myb/NN
./.
=====
C-myb/NN
and/CC
B-myb/NN
were/VBD
expressed/VBN
in/IN
all/DT
neoplastic/JJ
groups/NNS
,/,
except/IN
in/IN
CLL/NN
cells/NNS
./.
=====
Thus/RB
,/,
A-myb/NN
expression/NN
,/,
unlike/IN
that/DT
of/IN
c-myb/NN
and/CC
B-myb/NN
,/,
is/VBZ
restricted/JJ
to/TO
a/DT
subset/NN
of/IN
B-cell/NN
neoplasias/NN
(/(
in/IN
particular/JJ
BL/NN
and/CC
slg+B-ALL/NN
)/)
representative/NN
of/IN
a/DT
specific/JJ
stage/NN
of/IN
B-cell/NN
differentiation/NN
./.
=====
This/DT
expression/NN
may/NN
in/IN
part/NN
reflect/VBP
expression/NN
of/IN
A-myb/NN
by/IN
the/DT
normal/JJ
germinal/JJ
center/NN
B/NN
cells/NNS
that/WDT
are/VBP
the/DT
normal/JJ
counterpart/NN
of/IN
these/DT
transformed/VBN
B/NN
cells/NNS
./.
=====
The/DT
data/NNS
presented/VBN
strongly/RB
support/VBP
a/DT
role/NN
for/IN
this/DT
transcription/NN
factor/NN
in/IN
B-cell/NN
differentiation/NN
and/CC
perhaps/RB
in/IN
B-cell/NN
transformation/NN
in/IN
some/DT
neoplasias/NNS
./.